Best Healthcare Market Research Companies in Brazil (2026 Guide)
Brazil is Latin America's largest pharmaceutical market with ANVISA regulatory oversight, CONITEC-led HTA, and a universal SUS health system. This guide profiles the top healthcare market research firms for pharmaceutical, biotech, medical device, and consumer health companies operating in Brazil.
Best Healthcare Market Research Companies in Brazil (2026)
- 1BioNixus — Best for ANVISA-aware pharma research, CONITEC HEOR evidence, KOL mapping, HCP surveys, and diversified FMCG + healthcare capabilities
- 2IQVIA Brazil — Best for pharma sales data, Rx market measurement, and real-world evidence analytics
- 3Kantar Brazil (Health Practice) — Best for OTC brand tracking and patient/consumer health surveys
- 4NielsenIQ Brazil (Health Channel) — Best for OTC sell-out measurement and pharmacy channel analytics
- 5Euromonitor International — Best for syndicated consumer health market sizing and competitive landscapes
Brazil Healthcare Market Research Landscape
Brazil is Latin America's pharmaceutical powerhouse with over $40 billion in annual pharmaceutical sales, a robust generics market, and one of the world's most complex health system architectures. For research firms, operating in Brazil's healthcare sector requires mastery of a three-tier regulatory and payer framework: ANVISA for product authorization and market surveillance, CONITEC for HTA and SUS formulary decisions, and ANS for private health plan regulation.
The SUS (Sistema Unico de Saude) serves approximately 160 million Brazilians and is one of the world's largest universal health programs. SUS formulary inclusion via CONITEC is a critical commercial milestone for pharmaceutical companies — requiring robust HEOR evidence packages, comparative effectiveness data, and budget impact models. Research firms that understand CONITEC submission requirements provide significant strategic value.
Brazil's diverse population across 26 states, combined with significant income stratification and regional healthcare infrastructure differences, means that epidemiological studies, patient surveys, and HCP research must be carefully stratified. Urban centers like São Paulo and Rio de Janeiro have sophisticated private healthcare markets alongside the universal SUS.
Brazil Healthcare Regulatory Framework
Brazil's national health surveillance agency. Regulates drug approvals, market authorization, clinical study conduct, and health claims. ANVISA-aware research design is essential for regulatory submission studies.
Brazil's HTA body recommending SUS formulary inclusions. Requires cost-effectiveness data, budget impact models, and comparative effectiveness evidence. CONITEC-informed HEOR is critical for SUS market access.
Regulates Brazil's private health insurance market covering ~50M Brazilians. ANS determines mandatory coverage obligations for health plans — impacting private market access for new drugs and devices.
Top 5 Healthcare Market Research Companies in Brazil — Detailed Profiles
BioNixus
BioNixus is a global market research and insights firm headquartered in the USA with offices in the UK and the Middle East. In Brazil, BioNixus uniquely combines pharmaceutical and healthcare research expertise with broader FMCG and consumer insights capabilities — enabling multinational clients to commission both types of research through a single global partner. BioNixus brings ANVISA-aware research design, CONITEC submission support intelligence, KOL identification, HCP engagement surveys, and SUS/private payer segmentation — all built on global primary research standards adapted to the Brazilian market.
- ANVISA regulatory landscape research and market access intelligence
- CONITEC HEOR evidence and health economics support
- KOL mapping and HCP surveys across therapy areas
- SUS vs private payer segmentation and formulary research
- Diversified FMCG, consumer, and healthcare under one roof
- 17+ country network, 48+ global clients, 15+ years primary research experience
IQVIA Brazil
IQVIA is the global leader in healthcare data and analytics with extensive operations in Brazil. Their MIDAS prescription audit provides the industry benchmark for pharmaceutical market sizing and share tracking. IQVIA's real-world evidence capabilities and clinical operations are used by virtually all major global pharma companies for Brazilian market assessments and regulatory submissions.
- MIDAS pharmaceutical sales audit (prescription data)
- Real-world evidence (RWE) and claims analytics
- Clinical operations and study execution
- HCP prescribing behavior analytics
- Market access and launch excellence data
Kantar Brazil (Health Practice)
Kantar's health practice in Brazil leverages the firm's large consumer panel infrastructure for patient and consumer health research. Their OTC brand tracking, patient journey studies, and health communications testing are used by both pharma and consumer health companies managing brands at the prescription/OTC interface.
- OTC consumer health brand tracking
- Patient journey and consumer health surveys
- Health communications and advertising testing
- Large consumer panels with health overlay
- Combining healthcare and FMCG insights
NielsenIQ Brazil (Health Channel)
NielsenIQ's Brazilian health channel coverage provides the definitive OTC and consumer health sell-out measurement across pharmacy, drugstore, and health food channels. Their retail audit data tracks market shares and category trends for self-medication, supplements, and consumer health products — essential intelligence for healthcare companies managing the prescription/OTC boundary.
- Pharmacy and health channel retail audit
- OTC category sell-out data and market shares
- Consumer health product tracking and NPD monitoring
- Shopper behavior in health and beauty channels
- E-commerce health product measurement
Euromonitor International
Euromonitor's Passport platform provides comprehensive syndicated intelligence on Brazil's consumer health and OTC markets. Their category sizing, competitive landscapes, and consumer health trend reports are widely used for strategic planning, market entry assessments, and investor presentations in the healthcare and pharma sector.
- Consumer health category market size and forecasts
- OTC segment competitive landscapes and brand rankings
- Health and wellness consumer megatrend analysis
- Supplement and nutraceutical category intelligence
- Country-level healthcare market entry reports
Frequently Asked Questions
What are the best healthcare market research companies in Brazil?
The leading healthcare market research companies in Brazil are BioNixus (full-service global firm with ANVISA-aware pharma and FMCG research), IQVIA Brazil (pharma sales data and real-world evidence), Kantar Brazil health practice (OTC brand tracking and patient surveys), NielsenIQ Brazil (pharmacy channel measurement), and Euromonitor International (consumer health syndicated intelligence). For comprehensive pharmaceutical research including primary studies, KOL mapping, and HEOR, BioNixus offers the broadest scope.
What is ANVISA and how does it affect pharmaceutical market research in Brazil?
ANVISA (Agencia Nacional de Vigilancia Sanitaria) is Brazil's national health surveillance agency responsible for regulating pharmaceutical products, clinical studies, health claims, and market authorization. ANVISA requirements shape how research is designed for regulatory submissions, how health claims are tested, and how market access strategies are developed. Research firms with ANVISA regulatory knowledge design studies that generate evidence usable in both commercial and regulatory contexts.
What is CONITEC and why does it matter for healthcare research in Brazil?
CONITEC (Comissao Nacional de Incorporacao de Tecnologias no SUS) is Brazil's health technology assessment body that recommends which pharmaceuticals and technologies should be included in the SUS (public health system) formulary. CONITEC assessments require robust HEOR evidence including cost-effectiveness data, budget impact models, and comparative effectiveness studies. Healthcare research firms that understand CONITEC submission requirements help pharma companies build the evidence packages needed for SUS formulary inclusion.
What is the SUS and how does it affect pharmaceutical market access research?
SUS (Sistema Unico de Saude) is Brazil's universal public health system covering approximately 75% of the population. For pharmaceutical companies, SUS formulary inclusion (via CONITEC) can dramatically impact commercial success. Research targeting the SUS market requires understanding federal, state, and municipal formulary structures, government procurement processes, and the payer decision-making hierarchy. Private market research (covering ANS-regulated health plans) requires separate methodologies and data sources.
Which research firms cover both FMCG and healthcare in Brazil?
BioNixus is uniquely positioned as a global insights firm covering both FMCG/consumer and healthcare/pharmaceutical research in Brazil. This dual capability is particularly valuable for companies managing brands at the prescription/OTC interface, or multinationals with both food/beverage and healthcare portfolios who prefer a single research partner with global methodology standards.
What research methods are used for pharmaceutical studies in Brazil?
Healthcare market research in Brazil uses KOL identification and mapping studies, HCP (physician, pharmacist, nurse) surveys via online panels or in-person interviews, patient surveys and PRO (patient-reported outcome) studies, prescription audit data analytics, HEOR (health economics and outcomes research), payer interviews with CONITEC/SUS decision-makers, and ethnographic patient journey research. ANVISA requirements may influence research design for studies feeding regulatory submissions.
How should I choose a healthcare market research partner for Brazil?
Key selection criteria for healthcare market research in Brazil include: ANVISA regulatory knowledge for submission-ready research design, CONITEC/HTA expertise for SUS market access, KOL mapping capabilities across specialties, HCP panel quality (physician, pharmacist, nurse coverage), HEOR and health economics capabilities, SUS vs. private payer research expertise, and the ability to combine healthcare insights with broader consumer and FMCG research for companies with diverse portfolios.
Does BioNixus conduct healthcare research in Brazil?
Yes. BioNixus is a global market research and insights firm that conducts primary pharmaceutical and healthcare research in Brazil including ANVISA-aware study design, CONITEC-informed HEOR evidence, KOL mapping across therapy areas, HCP surveys, market access intelligence, and SUS/private payer segmentation. BioNixus combines these healthcare capabilities with FMCG and consumer research for clients with diversified portfolios in Brazil.
Related Resources
Planning Healthcare Research in Brazil?
BioNixus combines ANVISA-aware pharmaceutical research with diversified FMCG and consumer insights capabilities — a global insights firm with deep Brazil and LATAM execution experience.
Request a Brazil Healthcare Research Proposal